• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Mustang Bio Complies with Nasdaq Capital Market Requirement

    GLOBENEWSWIRE

    Mustang Bio Announces Data From Phase 1/2 Trial Of MB-106 CAR-T Therapy In WM

    GLOBENEWSWIRE

    Mustang Bio Announces Vision for CAR T-Cell Therapy Platform

    GLOBENEWSWIRE

    CAR-T for brain cancer extends survival in phase 1 trial

    FIERCE BIOTECH

    Mustang Bio Announces Publication of Data from Phase 1 Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

    GLOBENEWSWIRE

    Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106

    GLOBENEWSWIRE

    Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation

    GLOBENEWSWIRE

    Mustang Announces First Data from Multicenter Phase 1/2 Trial Evaluating MB-106

    GLOBENEWSWIRE

    Mustang Bio Announces FYR from Follicular Lymphoma Ph1/2 Trial of MB-106, CD20

    GLOBENEWSWIRE

    Mustang Bio Announces Results from Ongoing Phase 1/2 Clinical Trial of MB-106

    GLOBENEWSWIRE

    Mustang bucks some partnered cell, gene therapies

    FIERCE BIOTECH

    Mustang Announces Presentations of Clinical Data from Phase 1/2 Trial of MB-106

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.